934
C. K. Z. Andrade et al.
SPECIAL TOPIC
CH2), 3.60–3.90 (m, 1 H, CH), 2.70–2.90 (m, 1 H, CH), 1.90–2.20
(m, 2 H, CH2), 1.56 (s, 1 H, OH), 1.35 (d, 3 H, J = 6.9 Hz, CH3).
13C NMR (50 MHz, CDCl3): 16.4 (CH3, syn), 17.7 (CH3, anti),
38.9 (CH, anti), 39.5 (CH, syn), 45.3 (CH2), 74.9 (CH), 117.7 (CH,
anti), 118.1 (CH, syn), 126.4, 126.6, 127.7, 128.1, 128.4, 135.0,
143.2, 144.3.
13C NMR (50 MHz, CDCl3): = 43.3 (CH2), 57.1 (CH), 117.3 (CH),
118.3 (CH2), 125.5 (CH), 126.3 (CH), 127.0 (CH), 129.0 (CH),
134.6 (CH), 143.6 (C0), 147.4 (C0).
N-[1-(4-Nitrophenyl)-3-butenyl)]phenylamine (11)
IR (film): 3410, 3072, 2922, 2853, 1640, 1603, 1519, 1345, 993,
922, 854, 751, 693 cm–1.
1H NMR (200 MHz, CDCl3): = 8.18 (d, 2 H, J = 8.8 Hz, Ar), 7.54
(d, 2 H, J = 8.5 Hz, Ar), 7.03–7.13 (m, 2 H, Ar), 6.64–6.72 (m, 1 H,
Ar), 6.42 (dd, 2 H, J = 6.5, 2.0 Hz, Ar), 5.63–5.84 (m, 1 H, CH),
5.15–5.26 (m, 2 H, CH2), 4.50 (dd, 1 H, J = 8.0, 5.2 Hz, CH), 4.23
(br, 1 H, NH), 2.41–2.70 (m, 2 H, CH2).
MS: m/z (%) = 51 (12), 57 (11), 77 (34), 91 (73), 105 (100), 128
(41), 143 (26), 157 (15).
2-Methyl-1-phenyl-3-buten-1-ol (7)
IR (film): 3411, 1638, 1453, 761, 701 cm–1.
1H NMR (200 MHz, CDCl3): anti isomer: = 7.20–7.40 (m, 5 H,
Ph), 5.64–5.90 (m, 1 H, CH), 4.90–5.30 (m, 2 H, CH2), 4.35 (d, 1 H,
J = 7.8 Hz, CH), 2.50 (m, 1 H, CH), 1.60 (s, 1 H, OH), 0.86 (d, 3 H,
J = 6.8 Hz, CH3). syn isomer: = 7.20–7.40 (m, 5 H, Ph), 5.64-5.90
(m, 1 H, CH), 4.90–5.30 (m, 2 H, CH2), 4.60 (d, 1 H, J = 5.4 Hz,
CH), 2.50 (m, 1 H, CH), 2.00 (s, 1 H, OH), 1.00 (d, 3 H, J = 6.8 Hz,
CH3).
13C NMR (50 MHz, CDCl3): = 42.8 (CH2), 56.9 (CH), 113.5 (CH),
118.1 (CH2), 119.3 (CH2), 123.0 (CH), 127.3 (CH), 129.3 (CH),
133.4 (CH), 146.5 (C0), 147.1 (C0), 151.5 (C0).
MS: m/z (%) = 77 (1), 181 (39), 227 (100), 268 (0.2).
N-[1-(2-Furyl)-3-butenyl]phenylamine (12)
IR (film): 3411, 3077, 3052, 2918, 1640, 1603, 994, 921, 748, 691
13C NMR (50 MHz, CDCl3): = 14.0 (CH3, syn), 16.5 (CH3, anti),
44.6 (CH, syn), 46.1 (CH, anti), 77.2 (CH), 115.4 (CH2, syn), 116.7
(CH2, anti), 126.0, 126.8, 127.3, 127.6, 128.0, 128.2, 140.3 (CH,
syn), 142.6 (CH, anti).
cm–1.
1H NMR (200 MHz, CDCl3): = 7.33 (dd, 1 H, J = 1.8, 0.9 Hz, Ar),
7.08–7.22 (m, 2 H, Ar), 6.56–6.73 (m, 3 H, Ar), 6.27 (dd, 1 H,
J = 3.2, 1.8 Hz, Ar), 6.15 (dt, 1 H, J = 3.2, 0.8 Hz, Ar), 5.64–5.85
(m, 1 H, CH), 5.08–5.21 (m, 2 H, CH2), 4.54 (t, 1 H, J = 6.2 Hz,
CH), 3.97 (br, 1 H, NH), 2.61–2.68 (m, 2 H, CH2).
MS: m/z (%) = 51 (9), 65 (4), 77 (32), 79 (55), 107 (100), 129 (40),
144 (15).
1,2-Diphenyl-3-buten-1-ol (8)
Syn Isomer
IR (film): 3382, 3080, 1637, 1453, 750, 690 cm–1.
13C NMR (50 MHz, CDCl3): = 39.2 (CH2), 51.3 (CH), 106.0 (CH),
110.1 (CH), 113.5 (CH), 117.8 (CH), 118.4 (CH2), 129.1 (CH),
133.9 (CH), 141.5 (CH), 146.5 (C0), 155.3 (C0).
1H NMR (400 MHz, CDCl3): = 7.01–7.38 (m, 10 H, Ph), 5.89
(ddd, 1 H, J = 18.1, 10.3, 7.9 Hz, CH), 4.78–5.04 (m, 3 H, CH and
CH2), 3.63 (t, 1 H, J = 8.1 Hz, CH), 1.94 (s, 1 H, OH).
N-[1-(4-Chlorophenyl)-3-butenyl]phenylamine (13)
IR (film): 3413, 3077, 2925, 2852, 1639, 1601, 993, 918, 823, 749,
692 cm–1.
13C NMR (100 MHz, CDCl3): 58.5 (CH), 77.5 (CH), 117.2 (CH),
127.0, 127.8, 128.1, 128.7, 128.8, 137.0, 140.2, 141.9.
1H NMR (200 MHz, CDCl3): = 7.28 (s, 4 H, Ar), 7.02–7.12 (m, 2
H, Ar), 6.61–6.69 (m, 1 H, Ar), 6.41–6.48 (m, 2 H, Ar), 5.63–5.83
(m, 1 H, CH), 5.11–5.23 (m, 2 H, CH2), 4.35 (dd, 1 H, J = 7.9, 5.2
Hz, CH), 4.10 (br, 1 H, NH), 2.36–2.65 (m, 2 H, CH2).
MS: m/z (%) = 51 (52), 65 (20), 79 (88), 91 (51), 107 (95), 128
(100), 165 (4), 206 (7).
13C NMR (50 MHz, CDCl3): = 43.2 (CH2), 56.6 (CH), 113.5 (CH),
117.7 (CH2), 118.7 (CH2), 127.7 (CH), 128.8 (CH), 129.1 (CH),
132.6 (C0), 134.2 (CH), 142.2 (C0), 147.1 (C0).
Anti Isomer
1H NMR (400 MHz, CDCl3): = 7.00–7.38 (m, 10 H, Ph), 6.25
(ddd, 1 H, J = 19.1, 10.2, 8.9 Hz, CH), 5.10–5.30 (m, 3 H, CH and
CH2), 3.54 (t, 1 H, J = 8.3 Hz, CH), 2.34 (d, 1 H, J = 2.1 Hz, OH).
13C NMR (100 MHz, CDCl3): = 59.2 (CH), 77.2 (CH), 118.4
(CH), 126.5, 126.6, 127.4, 127.9, 128.3, 128.7, 137.8, 140.5, 141.7.
N-Butyl-1-(4-chlorophenyl)-3-butenyl-1-amine (14)
IR (film): 3331, 3077, 2928, 1640, 1639, 1595, 1090, 993, 917, 828,
741, 681 cm–1.
1H NMR (200 MHz, CDCl3): = 7.26 (d, 4 H, J = 1.7 Hz, Ar), 5.58–
5.80 (m, 1 H, CH), 5.02–5.12 (m, 2 H, CH2), 3.61 (t, 1 H, J = 6.8
Hz, CH), 2.30–2.45 (m, 4 H, 2 CH2), 1.53 (br, 1 H, NH), 1.18–1.49
(m, 4 H, 2 CH2), 0.86 (t, 3 H, J = 6.9 Hz, CH3).
13C NMR (50 MHz, CDCl3): = 14.0 (CH3), 20.4 (CH2), 32.4
(CH2), 43.2 (CH2), 47.4 (CH2), 61.9 (CH), 118.0 (CH), 128.4 (CH),
128.5 (CH), 132.4 (C0), 135.2 (CH), 142.8 (C0).
Allylation of Imines; General Procedure
To a fresh sublimed NbCl5 (1 mmol) suspension in CH2Cl2 (1.5 mL)
at –15 °C, under an argon atmosphere, was added a solution of the
imine (1 mmol) in CH2Cl2 (1.5 mL), followed by the addition of al-
lylstannane (2 mmol), after 10 min. The reaction was monitored by
TLC and after the consumption of the imine (1–2 h) it was quenched
with sat. NH4Cl (10 mL), extracted with Et2O (3 15 mL) and
stirred for 2 h with 10% KF in H2O (10 mL). The reaction mixture
was then washed several times with brine, dried with Na2SO4 and
concentrated at reduced pressure to furnish the crude product,
which was purified by silica gel chromatography (hexanes–EtOAc).
N-[1-(4-Methoxyphenyl)-3-butenyl]phenylamine (15)
IR (film): 3410, 3004, 2922, 2834, 1638, 1603, 1246, 993, 918, 829,
749, 692 cm–1.
1H NMR (200 MHz, CDCl3): = 7.28–7.35 (m, 2 H, Ar), 7.02–7.17
(m, 2 H, Ar), 6.86–6.93 (m, 2 H, Ar), 6.64–6.72 (m, 1 H, Ar), 6.51–
6.57 (m, 2 H, Ar), 5.70–5.90 (m, 1 H, CH), 5.14–5.27 (m, 2 H, CH2),
4.38 (dd, 1 H, J = 7.7, 5.4 Hz, CH), 4.18 (br, 1 H, NH), 3.82 (s, 3 H,
OCH3), 2.43–2.70 (m, 2 H, CH2).
13C NMR (50 MHz, CDCl3): = 43.2 (CH2), 55.2 (CH), 56.5 (CH3),
113.4 (CH), 113.9 (CH), 117.9 (CH), 118.2 (CH2), 127.3 (CH),
129.1 (CH), 134.8 (CH), 135.5 (C0), 147.4 (C0), 158.5 (C0).
N-(1-Phenyl-3-butenyl)phenylamine (10)
IR (film): 3411, 3078, 2853, 1640, 1601, 1452, 993, 917, 748, 692
cm–1.
1H NMR (200 MHz, CDCl3): = 7.17–7.39 (m, 5 H, Ar), 7.03–7.10
(m, 2 H, Ar), 6.59–6.67 (m, 1 H, Ar), 6.46–6.50 (m, 2 H, Ar), 5.65–
5.86 (m, 1 H, CH), 5.10–5.23 (m, 2 H, CH2), 4.37 (dd, 1 H, J = 7.9
and 5.2 Hz, CH), 4.15 (br, 1 H, NH), 2.39–2.68 (m, 2 H, CH2).
Synthesis 2002, No. 7, 928–936 ISSN 0039-7881 © Thieme Stuttgart · New York